Novel luciferase-based reporter system to monitor activation of ErbB2/Her2/neu pathway noninvasively during radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 79, Issue 1, 2011, Pages 233-238

  Wolf, Frank ^a   Li, Wenrong ^a   Li, Fang ^a   Li, Chuan Yuan ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

ErbB2 Her2 neu; Luciferase imaging; Radiotherapy; Reporter

Indexed keywords

BINDING PARTNERS; BREAST CANCER CELLS; C-TERMINAL FRAGMENTS; ERBB2/HER2/NEU; FUSION PROTEINS; IN-VITRO; IN-VIVO; LUCIFERASE IMAGING; N-TERMINALS; NON-INVASIVE MONITORING; RECEPTOR ACTIVATION; REPORTER; REPORTER SYSTEMS; THERAPEUTIC AGENTS;

BIOLOGICAL MATERIALS; TUMORS;

RADIOTHERAPY;

EPIDERMAL GROWTH FACTOR RECEPTOR 2; LUCIFERASE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN SHC;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLUMINESCENCE; BREAST CANCER; CANCER CELL; CANCER RADIOTHERAPY; CARBOXY TERMINAL SEQUENCE; CYTOTOXICITY; IN VIVO CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE STUDY; RECEPTOR BINDING; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BLOTTING, WESTERN; CELL LINE, TUMOR; EPIDERMAL GROWTH FACTOR; GENES, REPORTER; GENETIC VECTORS; LENTIVIRUS; LUCIFERASES; LUMINESCENT PROTEINS; MICE; MICE, NUDE; MITOGEN-ACTIVATED PROTEIN KINASES; NEUREGULIN-1; PACLITAXEL; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECOMBINANT FUSION PROTEINS; SHC SIGNALING ADAPTOR PROTEINS; SIGNAL TRANSDUCTION;

EID: 78650011214     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.08.001     Document Type: Article

References (22)

1. R.S. Negrin, and C.H. Contag In vivo imaging using bioluminescence: A tool for probing graft-versus-host disease Nat Rev Immunol 6 2006 484 490
2. M. Edinger, T.J. Sweeney, and A.A. Tucker Noninvasive assessment of tumor cell proliferation in animal models Neoplasia 1 1999 303 310
3. K. Kamei, T.O. Ishikawa, and H.R. Herschman Transgenic mouse for conditional, tissue-specific Cox-2 overexpression Genesis 44 2006 177 182
4. S.K. Lyons, E. Lim, and A.O. Clermont Noninvasive bioluminescence imaging of normal and spontaneously transformed prostate tissue in mice Cancer Res 66 2006 4701 4707
5. N. Klopstock, C. Levy, and D. Olam Testing transgenic regulatory elements through live mouse imaging FEBS Lett 581 2007 3986 3990
6. T. Ozawa, A. Kaihara, and M. Sato Split luciferase as an optical probe for detecting protein-protein interactions in mammalian cells based on protein splicing Anal Chem 73 2001 2516 2521
7. V. Villalobos, S. Naik, and D. Piwnica-Worms Current state of imaging protein-protein interactions in vivo with genetically encoded reporters Annu Rev Biomed Eng 9 2007 321 349
8. W. Li, F. Li, and Q. Huang Noninvasive imaging and quantification of epidermal growth factor receptor kinase activation in vivo Cancer Res 68 2008 4990 4997
9. F. Li, P. Sonveaux, and Z.N. Rabbani Regulation of HIF-1alpha stability through S-nitrosylation Mol Cell 26 2007 63 74
10. D.J. Slamon, G.M. Clark, and S.G. Wong Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene Science 235 1987 177 182
11. M.F. Press, L. Bernstein, and P.A. Thomas HER-2/neu gene amplification characterized by fluorescence in situ hybridization: Poor prognosis in node-negative breast carcinomas J Clin Oncol 15 1997 2894 2904
12. J. Mendelsohn, and J. Baselga The EGF receptor family as targets for cancer therapy Oncogene 19 2000 6550 6565
13. D.G. Haller Future directions in the treatment of pancreatic cancer Semin Oncol 29 2002 31 39
14. R.A. Wolff Novel therapies for pancreatic cancer Cancer J 7 2001 349 358
15. D.F. Stern, and M.P. Kamps EGF-stimulated tyrosine phosphorylation of p185neu: A potential model for receptor interactions EMBO J 7 1988 995 1001
16. D. Harari, and Y. Yarden Molecular mechanisms underlying ErbB2/HER2 action in breast cancer Oncogene 19 2000 6102 6114
17. M.A. Olayioye, R.M. Neve, and H.A. Lane The ErbB signaling network: Receptor heterodimerization in development and cancer EMBO J 19 2000 3159 3167
18. E. Tzahar, R. Pinkas-Kramarski, and J.D. Moyer Bivalence of EGF-like ligands drives the ErbB signaling network EMBO J 16 1997 4938 4950
19. M. Alimandi, A. Romano, and M.C. Curia Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas Oncogene 10 1995 1813 1821
20. T. Holbro, R.R. Beerli, and F. Maurer The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation Proc Natl Acad Sci USA 100 2003 8933 8938
21. R. Zufferey, D. Nagy, and R.J. Mandel Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo Nat Biotechnol 15 1997 871 875
22. F. Pasleau, M. Grooteclaes, and R. Gol-Winkler Expression of the c-ErbB2 gene in the BT474 human mammary tumor cell line: Measurement of c-ErbB2 mRNA half-life Oncogene 8 1993 849 854